The Role of the Juxtamembrane Domain of FLT3-ITDs in Acute Myeloid Leukemia

The Role of the Juxtamembrane Domain of FLT3-ITDs in Acute Myeloid Leukemia

HASH(0x641f788)

Bibliographic Details
Main Author:	Vempati, Sridhar
Format:	Others
Published:	lmu 2007
Subjects:	Medizinische Fakultät
Online Access:	http://edoc.ub.uni-muenchen.de/7015/1/Vempati_Sridhar.pdf http://nbn-resolving.de/urn:nbn:de:bvb:19-70158

Similar Items

Mutationen des FLT3 Genes in akuter myeloider Leukaemie
by: Bagrintseva, Ksenia
Published: (2005)

Proteomics of Acute Myeloid Leukemia:
by: Yaseen, Mumtaz
Published: (2007)

Deletion and deletion/insertion mutations in the juxtamembrane domain of the FLT3 gene in adult acute myeloid leukemia
by: Kristin K. Deeb, et al.
Published: (2014-01-01)

Mechanism of sorafenib resistance in FLT3-ITD⁺ acute myeloid leukemia
by: Man, Cheuk-him, et al.
Published: (2014)

Comparison of FLT3 inhibitors with the standard treatment for FLT3-ITD mutated acute myeloid leukemia
by: Argetsinger, Stephanie
Published: (2019)

Gab2 is Essential for Transformation by FLT3-ITD in Acute Myeloid Leukemia
by: Katharina Sies, et al.
Published: (2019-04-01)

AML1/ETO Downregulates the Transcription Factor PU.1 in Acute Myeloid Leukemia
by: Vangala, Rajani Kanth
Published: (2003)

Max as a novel co-activator of myeloid transcription factor C/EBPα and the critical role of PIN1 in Acute Myeloid Leukemia with C/EBPα mutation
by: Pulikkan, John Anto
Published: (2008)

The four and a half LIM domain protein 2 (FHL2) interacts with CALM and is highly expressed in acute myeloid leukemia (AML) with complex aberrant karyotypes
by: Pasalic, Zlatana
Published: (2008)

Autophagy activation mediates resistance to FLT3 inhibitors in acute myeloid leukemia with FLT3-ITD mutation
by: Chen, Y., et al.
Published: (2022)

Die FLT3 Längenmutation in de akuten myeloischen Leukämie
by: Malamoussi, Theodora
Published: (2009)

NPM1 and FLT3-ITD/TKD Gene Mutations in Acute Myeloid Leukemia
by: Shano Naseem, et al.
Published: (2021-01-01)

Proto-oncogene c-jun expression is induced by AML1-ETO in a JNK dependent manner:possible role in the pathogenesis of acute myeloid leukemia
by: Elsaesser, Annika
Published: (2003)

Aberrante Aktivierung der Rezeptortyrosinkinase FLT3 in der akuten myeloischen Leukämie
by: Reindl, Carola
Published: (2007)

Signaling through CD44 affects cell cycle progression and c-Jun expression in acute myeloid leukemia cells
by: Peer Zada, Abdul Ali
Published: (2004)

Follistatin is a novel therapeutic target and biomarker in FLT3/ITD acute myeloid leukemia
by: Bai‐Liang He, et al.
Published: (2020-04-01)

A dual inhibitor overcomes drug-resistant FLT3-ITD acute myeloid leukemia
by: Peihong Wang, et al.
Published: (2021-07-01)

Follistatin is a novel therapeutic target and biomarker in FLT3/ITD acute myeloid leukemia
by: Bai‐Liang He, et al.
Published: (2020-08-01)

FMS-LIKE TYROSINE KINASE (FLT3) GENE ITD MUTATION IN ACUTE MYELOID LEUKEMIA
by: Rajko Kusec, et al.
Published: (2004-12-01)

Proteomic identification of C/EBPa multiprotein complex reveals that JNK1, an activator of C/EBPa is downregulated in patients with acute myeloid leukemia (AML)
by: Trivedi, Arun Kumar
Published: (2006)

Proteomic analysis of acute promyelocytic leukemia
by: Geletu Heye, Mulu
Published: (2006)

Induktion von Wachstumsarrest und Apoptose in leukämischen Zelllinien durch selektive Inhibition der mutierten Rezeptortyrosinkinase FLT3
by: Dirschinger, Ralf
Published: (2007)

Die Bedeutung von Mutationen der Rezeptortyrosinkinase FLT3 für die Resistenzentstehung in der akuten myeloischen Leukämie
by: Geisenhof, Stefanie
Published: (2007)

Funktionelle Charakterisierung von extrazellulären Mutationen der Rezeptortyrosinkinasen KIT und FLT3 in der akuten myeloischen Leukämie
by: Kohl, Tobias
Published: (2005)

Imipramine blue sensitively and selectively targets FLT3-ITD positive acute myeloid leukemia cells
by: Jonathan Metts, et al.
Published: (2017-06-01)

The sensitivity of the FLT3-ITD detection method is an important consideration when diagnosing acute myeloid leukemia
by: Masahiro Sakaguchi, et al.
Published: (2020-01-01)

Chronic FLT3-ITD Signaling in Acute Myeloid Leukemia Is Connected to a Specific Chromatin Signature
by: Pierre Cauchy, et al.
Published: (2015-08-01)

Resveratrol Targets Sphingolipid Metabolism to Induce Growth Inhibition in FLT3 ITD Acute Myeloid Leukemia
by: Nur Şebnem Ersöz, et al.
Published: (2019-12-01)

Characterisation of the Leukemic Stem Cell in a Murine Model of CALM/AF10 Positive Myeloid Leukemia
by: Deshpande, Aniruddha
Published: (2006)

Natural small molecule triptonide inhibits lethal acute myeloid leukemia with FLT3-ITD mutation by targeting Hedgehog/FLT3 signaling
by: Ying Xu, et al.
Published: (2021-01-01)

Surface marker expression profiles of dendritic cells (DC) generated from blasts in patients with acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) are valuable tools to characterize and quantify DC in experimental settings
by: Dreyßig, Julia
Published: (2010)

Ectopic expression of the homeobox gene Cdx2 is the key transforming event in a mouse model of t(12;13)(p13;q12) acute myeloid leukemia; a novel mechanism in AML
by: Rawat, Vijay Pal Singh
Published: (2006)

ULK1 inhibition as a targeted therapeutic strategy for FLT3-ITD-mutated acute myeloid leukemia
by: Doh Yu Hwang, et al.
Published: (2020-05-01)

Cytogenetics and FLT3-ITD mutation predict clinical outcomes in non transplant patients with acute myeloid leukemia
by: Pimjai Niparuck, et al.
Published: (2019-01-01)

Data-Driven Math Model of FLT3-ITD Acute Myeloid Leukemia Reveals Potential Therapeutic Targets
by: David J. Wooten, et al.
Published: (2021-03-01)

Angiogenesefaktoren PlGF, sFlt-1 und sEng in unauffälligen Schwangerschaften und bei Präeklampsie
by: Thomas, Veronika
Published: (2012)

Sorafenib for relapsed FLT3‐ITD‐positive acute myeloid leukemia postallogeneic stem cell transplantation presenting as leukemia cutis
by: Rachel Brodie, et al.
Published: (2019-12-01)

FLT3-ITD Incidence and FLT-D835 Mutations in Acute Myeloid Leukemia Patients with Normal Karyotype in Morocco: A Preliminary Study
by: Hind Dehbi, et al.
Published: (2013-01-01)

CD52 is a novel target for the treatment of FLT3-ITD-mutated myeloid leukemia
by: Sivasundaram Karnan, et al.
Published: (2021-05-01)

FLT3-ITD Mutation and FLT3 Ligand Plasma Level Were Not Associated with One-Year Survival of Indonesian Acute Myeloid Leukemia Patients
by: Rinaldi I, et al.
Published: (2021-02-01)